We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$87.2B
AUM Growth
-$982M
Cap. Flow
-$1.89B
Cap. Flow %
-2.16%
Top 10 Hldgs %
17.52%
Holding
2,206
New
298
Increased
599
Reduced
739
Closed
319

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$291M
2
HSY icon
Hershey
HSY
+$278M
3
CVX icon
Chevron
CVX
+$274M
4
APD icon
Air Products & Chemicals
APD
+$268M
5
SAP icon
SAP
SAP
+$240M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$347M
2
DG icon
Dollar General
DG
+$290M
3
WDAY icon
Workday
WDAY
+$225M
4
PINS icon
Pinterest
PINS
+$165M
5
INTU icon
Intuit
INTU
+$150M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Healthcare 12.88%
3 Financials 11.68%
4 Industrials 10.33%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMTL icon
1676
Comtech Telecommunications
CMTL
$51.8M
$4.36K ﹤0.01%
+1,438
New +$3.41K
ATOM icon
1677
Atomera
ATOM
$201M
$4.32K ﹤0.01%
+1,133
New +$5.34K
PETS icon
1678
PetMed Express
PETS
$42.5M
$4.21K ﹤0.01%
+1,039
New +$4.44K
CERT icon
1679
Certara
CERT
$1.17B
$4.2K ﹤0.01%
+303
New +$4.98K
PDSB icon
1680
PDS Biotechnology
PDSB
$38.1M
$4.16K ﹤0.01%
+1,420
New +$4.54K
TSE
1681
DELISTED
Trinseo
TSE
$4.15K ﹤0.01%
+1,805
New +$5.62K
KYNB
1682
Kyntra Bio
KYNB
$28.5M
$4.15K ﹤0.01%
+186
New +$5.75K
AMWL icon
1683
American Well
AMWL
$181M
$4.14K ﹤0.01%
+637
New +$6.41K
EXFY icon
1684
Expensify
EXFY
$166M
$4.14K ﹤0.01%
+2,776
New +$4.38K
GRC icon
1685
Gorman-Rupp
GRC
$2.16B
$4.11K ﹤0.01%
+112
New +$3.96K
ENVA icon
1686
Enova International
ENVA
$5.91B
$4.11K ﹤0.01%
+66
New +$4.03K
VUZI icon
1687
Vuzix
VUZI
$190M
$4.09K ﹤0.01%
+3,033
New +$4.18K
PLX icon
1688
Protalix BioTherapeutics
PLX
$191M
$4.05K ﹤0.01%
+3,460
New +$4.09K
CTXR icon
1689
Citius Pharmaceuticals
CTXR
$14.3M
$4.02K ﹤0.01%
+275
New +$4.93K
MBIO icon
1690
Mustang Bio
MBIO
$4.26M
$4K ﹤0.01%
160
SGMT icon
1691
Sagimet Biosciences
SGMT
$437M
$3.99K ﹤0.01%
+1,167
New +$5.35K
ACRS icon
1692
Aclaris Therapeutics
ACRS
$730M
$3.85K ﹤0.01%
+3,497
New +$4.11K
CNTY icon
1693
Century Casinos
CNTY
$32.9M
$3.82K ﹤0.01%
+1,379
New +$4K
GWH icon
1694
ESS Tech
GWH
$22.1M
$3.82K ﹤0.01%
+311
New +$3.5K
OPTN
1695
DELISTED
OptiNose
OPTN
$3.82K ﹤0.01%
+245
New +$4.1K
TELA icon
1696
TELA Bio
TELA
$30.9M
$3.78K ﹤0.01%
+805
New +$4.24K
MCRB icon
1697
Seres Therapeutics
MCRB
$48M
$3.58K ﹤0.01%
+247
New +$4.12K
GHC icon
1698
Graham Holdings Company
GHC
$4.97B
$3.49K ﹤0.01%
+5
New +$3.65K
FOSL icon
1699
Fossil Group
FOSL
$239M
$3.47K ﹤0.01%
+2,411
New +$2.74K
ALLK
1700
DELISTED
Allakos
ALLK
$3.42K ﹤0.01%
+3,422
New +$4.07K

Similar funds

Macquarie Group's Q2 2024 Portfolio in Review

As of Q2 2024, Macquarie Group held 2,206 positions worth $87.2B, down 1.1% from $88.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Macquarie Group's Q2 2024 filing shows 298 new, 599 increased, 739 reduced and 319 closed positions. Its largest new stake was AppFolio: 251,518 shares worth $61.5M. The largest sale was American International, an estimated $347M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q2 2024 buy was AppFolio: 251,518 shares worth $61.5M.
  • Macquarie Group added most to Jacobs Solutions in Q2 2024, an estimated $291M increase.
  • Macquarie Group's biggest Q2 2024 reduction was American International, cutting an estimated $347M.
  • Macquarie Group fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $110M.
  • Macquarie Group's ten largest holdings make up 18% of its $87.2B portfolio in Q2 2024.
  • Macquarie Group opened 298 new positions and closed 319 in Q2 2024.
  • Macquarie Group's portfolio value fell 1.1% quarter-over-quarter to $87.2B.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.